Ebiox Supply Agreement

RNS Number:1860A
Healthcare Enterprise Group PLC
13 July 2007

13 July 2007

Healthcare Enterprise Group PLC

Ebiox Distribution Agreement with Medtradex



Healthcare Enterprise Group PLC ("HCEG", AIM: HCEG) announces that its wholly
owned subsidiary, Ebiox Limited, has secured a supply agreement with Medtradex
bvba and Simovision BV ("Medtradex") for the marketing and distribution of the
Ebiox range of cleaning and disinfection products to the acute healthcare sector
in the Benelux region.



The agreement which is for an initial term of two years will produce minimum
sales of Euro320,000 renewable at the end of each term.



Medtradex is a leading distributor of ophthalmic implants and decontamination
units, throughout the Benelux region.



In addition, as various Ebiox products are introduced, Medtradex will market
these products in the Benelux region, and in their specified sector.



Marc Simonet, Chief Executive of Medtradex commented:



"We selected the advanced Ebiox product range due to the extensive efficacy
profile, the complete suite of products and the compatibility with delicate
ophthalmic devices.  Medtradex have recruited additional resource to focus on
the marketing and distribution of the Ebiox product range and expect to increase
their penetration into the acute health centre market."



Lyndon Gaborit, HCEG Executive Deputy Chairman commented:



"Our partnership with Medratex in an important step for Ebiox in Europe and
shows steady progress of the product as it gains in reputation.  We are
delighted that Medratex has chosen Ebiox as one of its key opthamic
decontamination products."



Enquiries:

Healthcare Enterprise Group                              + 44 (0)1925 898 200
Lyndon Gaborit, Executive Deputy Chairman

College Hill                                              [phone]
Adrian Duffield / Corinna Dorward



Notes to editors



Healthcare Enterprise Group PLC - is a business engaged in medical product
distribution, occupational health, and first aid markets.  These businesses
underpin a range of innovative medical devices. HCEG is listed on the
Alternative Investment Market (AIM) of the London Stock Exchange.

Ebiox - Patented decontamination and disinfectant products that are safe and
alcohol free but substantially more effective than conventional methods at
destroying embedded microorganisms.  The Ebiox range includes hand hygiene
products, surface disinfectants, products to clean and decontaminate surgical
instruments, and dental cleaning products.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

AGROKBKQOBKDAOD